| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.093 | 0.1 |